; and (4) explore opportunities to partner with the Department of Defense and the Department of Veterans Affairs to increase research and improve patient care regarding ME/CFS that commonly impact veterans and active duty military personnel. (f) Report to Congress Not later than 24 months after the date of enactment of the Understanding COVID–19 Subsets and ME/CFS Act , the Director of NIH shall submit a report to Congress on the progress made in gathering data and expanding research on the onset and clinical care of COVID–19 survivors with ME/CFS, including the rate at which COVID–19 survivors are diagnosed with ME/CFS. Such report shall summarize the grants and research funded, by year, under this section. (g) Authorization of appropriations There is authorized to be appropriated to carry out this section $15,000,000 for each of fiscal years 2020 through 2024. . 4. Promoting public awareness of post-viral chronic neuroimmune diseases Part B of title III of the Public Health Service Act ( 42 U.S.C. 243 et seq.) is amended by adding at the end the following: 320B. Public awareness of post-viral chronic neuroimmune diseases (a) In general The Secretary may engage in public awareness and education activities to increase understanding and recognition of post-viral chronic neuroimmune diseases, specifically myalgic encephalomyelitis/chronic fatigue syndrome (in this section referred to as ME/CFS ). (b) Activities included Activities under subsection (a) may include the distribution of print, film, and web-based materials targeting health care providers and the public and prepared and disseminated in conjunction with patient organizations that conduct research on or treat ME/CFS. (c) Emphasis The information expressed through activities under subsection (a) shall emphasize— (1) basic information on ME/CFS, the symptoms, prevalence, and frequently co-occurring conditions; and (2) the importance of early diagnosis, and prompt and accurate treatment of ME/CFS, including most recent treatment recommendations. .